ATE271860T1 - Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit - Google Patents

Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Info

Publication number: ATE271860T1
Authority: AT; Austria
Prior art keywords: endometriosis; infertility; fertility; treatment; increase
Prior art date: 1999-10-05

Application number

AT00964272T

Other languages

English (en)

Inventor

William J Bologna

Dominique De Ziegler

Howard L Levine

Original Assignee

Columbia Lab Bermuda Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-05

Filing date

2000-10-04

Publication date

2004-08-15

2000-10-04 Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd

2004-08-15 Application granted granted Critical

2004-08-15 Publication of ATE271860T1 publication Critical patent/ATE271860T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pregnancy & Childbirth (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT00964272T 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit ATE271860T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15775499P	1999-10-05	1999-10-05
US66838400A	2000-09-25	2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en)	1999-10-05	2000-10-04	Treating endometriosis or infertility, or improving fertility

Publications (1)

Publication Number	Publication Date
ATE271860T1 true ATE271860T1 (de)	2004-08-15

Family

ID=26854456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00964272T ATE271860T1 (de)	1999-10-05	2000-10-04	Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Country Status (28)

Country	Link
EP (1)	EP1220667B1 (de)
JP (2)	JP2003510354A (de)
KR (1)	KR100738724B1 (de)
CN (1)	CN1218694C (de)
AR (1)	AR028487A1 (de)
AT (1)	ATE271860T1 (de)
AU (1)	AU780736B2 (de)
BR (1)	BR0014548A (de)
CA (1)	CA2385974C (de)
CO (1)	CO5251423A1 (de)
DE (1)	DE60012554T2 (de)
DK (1)	DK1220667T3 (de)
ES (1)	ES2223581T3 (de)
GE (1)	GEP20043313B (de)
HK (1)	HK1044120B (de)
HU (1)	HU225990B1 (de)
IL (2)	IL148784A0 (de)
MA (1)	MA25501A1 (de)
MX (1)	MXPA02003453A (de)
MY (1)	MY129518A (de)
NO (1)	NO329663B1 (de)
NZ (1)	NZ518429A (de)
PE (1)	PE20010742A1 (de)
PT (1)	PT1220667E (de)
TR (1)	TR200200899T2 (de)
TW (1)	TWI280877B (de)
UA (1)	UA74168C2 (de)
WO (1)	WO2001024788A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101327326A (zh) *	2001-10-29	2008-12-24	哥伦比亚实验室(百慕大群岛)有限公司	阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en)	2001-10-29	2013-04-23	Columbia Laboratories, Inc.	Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es)	2003-07-16	2006-11-01	Italfarmaco, S.A.	Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (de)	2006-06-29	2008-01-02	Polichem S.A.	Verwendung einer hydrophilen Matrix, die ein Polyacrylsäurederivat, einen Celluloseether und ein Zerfallsmittel enthält, für die Herstellung eines Medikamentes zur Behandlung weiblicher Genitalstörungen
ES2344673B1 (es)	2008-08-07	2011-05-03	Italfarmaco, S.A.	Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es)	2008-12-19	2011-04-28	Italfarmaco, S.A.	Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
MX2012010327A (es) *	2010-03-22	2012-11-16	Repros Therapeutics Inc	Composiciones y metodos para la administracion no toxica de antiprogestinas.
KR101010031B1 (ko) *	2010-12-08	2011-01-21	류상범	흡수식 냉온수기용 엘리미네이터
SG11201407397WA (en)	2012-05-31	2014-12-30	Repros Therapeutics Inc	Formulations and methods for vaginal delivery of antiprogestins
AU2013338305B2 (en)	2012-11-02	2018-06-07	Allergan pharmaceuticals International Ltd.	Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4241087A (en) *	1979-04-02	1980-12-23	William H. Rorer, Inc.	Dysmenorrhea treatment
AU5068090A (en) *	1989-03-07	1990-09-13	Adeza Biomedical Corporation	Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) *	1990-04-12	1997-04-23	雪印乳業株式会社	子宮内膜症治療剤
IT1251114B (it) *	1991-07-26	1995-05-04	Farcon Ag	Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) *	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

2000
- 2000-04-10 UA UA2002043631A patent/UA74168C2/uk unknown
- 2000-10-03 MY MYPI20004608A patent/MY129518A/en unknown
- 2000-10-03 PE PE2000001044A patent/PE20010742A1/es not_active Application Discontinuation
- 2000-10-04 HU HU0203050A patent/HU225990B1/hu unknown
- 2000-10-04 EP EP00964272A patent/EP1220667B1/de not_active Expired - Lifetime
- 2000-10-04 CA CA2385974A patent/CA2385974C/en not_active Expired - Fee Related
- 2000-10-04 IL IL14878400A patent/IL148784A0/xx active IP Right Grant
- 2000-10-04 NZ NZ518429A patent/NZ518429A/en not_active IP Right Cessation
- 2000-10-04 PT PT00964272T patent/PT1220667E/pt unknown
- 2000-10-04 WO PCT/EP2000/009708 patent/WO2001024788A2/en active IP Right Grant
- 2000-10-04 CO CO00075387A patent/CO5251423A1/es not_active Application Discontinuation
- 2000-10-04 JP JP2001527787A patent/JP2003510354A/ja active Pending
- 2000-10-04 DE DE60012554T patent/DE60012554T2/de not_active Expired - Lifetime
- 2000-10-04 TR TR2002/00899T patent/TR200200899T2/xx unknown
- 2000-10-04 BR BR0014548-3A patent/BR0014548A/pt not_active Application Discontinuation
- 2000-10-04 ES ES00964272T patent/ES2223581T3/es not_active Expired - Lifetime
- 2000-10-04 AT AT00964272T patent/ATE271860T1/de active
- 2000-10-04 AU AU75250/00A patent/AU780736B2/en not_active Ceased
- 2000-10-04 CN CNB008138079A patent/CN1218694C/zh not_active Expired - Fee Related
- 2000-10-04 GE GE4769A patent/GEP20043313B/en unknown
- 2000-10-04 AR ARP000105228A patent/AR028487A1/es unknown
- 2000-10-04 DK DK00964272T patent/DK1220667T3/da active
- 2000-10-04 KR KR1020027004330A patent/KR100738724B1/ko not_active IP Right Cessation
- 2000-10-04 MX MXPA02003453A patent/MXPA02003453A/es active IP Right Grant
- 2000-10-27 TW TW089120706A patent/TWI280877B/zh not_active IP Right Cessation
2002
- 2002-03-20 IL IL148784A patent/IL148784A/en not_active IP Right Cessation
- 2002-04-04 MA MA26584A patent/MA25501A1/fr unknown
- 2002-04-04 NO NO20021591A patent/NO329663B1/no not_active IP Right Cessation
- 2002-08-01 HK HK02105660.6A patent/HK1044120B/zh not_active IP Right Cessation
2009
- 2009-10-29 JP JP2009249023A patent/JP2010018639A/ja active Pending

Also Published As

Publication number	Publication date
PT1220667E (pt)	2004-11-30
HU225990B1 (en)	2008-02-28
DE60012554T2 (de)	2005-11-24
IL148784A (en)	2006-12-31
MA25501A1 (fr)	2002-07-01
HK1044120A1 (en)	2002-10-11
HUP0203050A2 (hu)	2003-02-28
ES2223581T3 (es)	2005-03-01
NO20021591L (no)	2002-05-28
CN1218694C (zh)	2005-09-14
AR028487A1 (es)	2003-05-14
WO2001024788A3 (en)	2001-12-06
NO329663B1 (no)	2010-11-29
EP1220667B1 (de)	2004-07-28
PE20010742A1 (es)	2001-07-19
CA2385974C (en)	2010-01-26
GEP20043313B (en)	2004-03-10
MY129518A (en)	2007-04-30
AU780736B2 (en)	2005-04-14
UA74168C2 (uk)	2005-11-15
CA2385974A1 (en)	2001-04-12
WO2001024788A2 (en)	2001-04-12
BR0014548A (pt)	2002-06-04
DE60012554D1 (de)	2004-09-02
CN1377264A (zh)	2002-10-30
TR200200899T2 (tr)	2002-07-22
KR20020062285A (ko)	2002-07-25
HUP0203050A3 (en)	2006-02-28
DK1220667T3 (da)	2004-12-06
JP2003510354A (ja)	2003-03-18
MXPA02003453A (es)	2002-08-20
AU7525000A (en)	2001-05-10
IL148784A0 (en)	2002-09-12
TWI280877B (en)	2007-05-11
JP2010018639A (ja)	2010-01-28
CO5251423A1 (es)	2003-02-28
EP1220667A2 (de)	2002-07-10
NZ518429A (en)	2004-02-27
NO20021591D0 (no)	2002-04-04
HK1044120B (zh)	2004-12-17
KR100738724B1 (ko)	2007-07-12

Publication	Publication Date	Title
ATE250575T1 (de)	2003-10-15	Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
ATE329911T1 (de)	2006-07-15	Fsh mimetika zur behandlung von infertilität
DE69716525D1 (de)	2002-11-28	Handgelenkstütze zur Behandlung des Karpaltunnelsyndroms
FI972205A0 (fi)	1997-05-23	cGmp-PDE:n estäjiä erektiohäiriön hoidossa
DE60020820D1 (de)	2005-07-21	Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
ATE293610T1 (de)	2005-05-15	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60130675D1 (de)	2007-11-08	Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose
NL300258I2 (nl)	2007-05-01	Farmaceutische samenstelling voor toepassing in debehandeling van.
IS2494B (is)	2009-02-15	Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
ATE254458T1 (de)	2003-12-15	Antibiotische zusammensetzungen zur behandlung des auges
ID30276A (id)	2001-11-15	Metode untuk mengobati gangguan-gangguan seksual
ATE293447T1 (de)	2005-05-15	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69819515D1 (de)	2003-12-11	Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
ATE271860T1 (de)	2004-08-15	Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit
HUP0200912A2 (en)	2002-08-28	Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction
DE60031790D1 (de)	2006-12-21	Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
ATE276262T1 (de)	2004-10-15	Oxazinochinolone für die behandlung viraler infektionen
DE59707096D1 (de)	2002-05-29	Haarbehandlungsmittel zur Festigung der Haare
MXPA03004303A (es)	2003-08-19	DERIVADOS SUSTITUIDOS DE ACIDO AMINO-FURAN-2-IL-ACETICO Y ACIDO AMINO-TIEN-2-IL-ACETICO Y SU USO PARA EL TRATAMIENTO DE MIGRAnA Y DOLOR.
DE69905214D1 (de)	2003-03-13	Mittel zur Behandlung der Osteoporose
DE69822297D1 (de)	2004-04-15	Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE347888T1 (de)	2007-01-15	Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
PT1051172E (pt)	2005-03-31	Metodo para tratamento da dpco
PT1200447E (pt)	2004-02-27	Oxazinocarbazoles para o tratamento de doencas do snc
LU90315B1 (de)	2000-05-08	Verfahren zur thermischen Behandlung schwermetallhaltiger Reststoffe

Legal Events

Date	Code	Title	Description
2005-08-15	UEP	Publication of translation of european patent specification	Ref document number: 1220667 Country of ref document: EP

Date

Code

Title

Description

2005-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1220667

Country of ref document: EP